Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting protein arginine methyltransferase 5 in cancers: Roles, inhibitors and mechanisms
Yingqing Chen, Xiaomin Shao, Xiangge Zhao, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 144, pp. 112252-112252
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Recent advances of IDH1 mutant inhibitor in cancer therapy
Wangqi Tian, Weitong Zhang, Yifan Wang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 56
Targeting Arginine Methyltransferase PRMT5 for Cancer Therapy: Updated Progress and Novel Strategies
Jiahong Zheng, Bang Li, Yingqi Wu, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 13, pp. 8407-8427
Closed Access | Times Cited: 39
STC2 activates PRMT5 to induce radioresistance through DNA damage repair and ferroptosis pathways in esophageal squamous cell carcinoma
Kan Jiang, Xin Yin, Qingyi Zhang, et al.
Redox Biology (2023) Vol. 60, pp. 102626-102626
Open Access | Times Cited: 38
Rhodiola rosea: A Therapeutic Candidate on Cardiovascular Diseases
Yingqing Chen, Minli Tang, Shuo Yuan, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-14
Open Access | Times Cited: 35
Medicinal chemistry strategies targeting PRMT5 for cancer therapy
Siyu Fu, Qinwen Zheng, Dan Zhang, et al.
European Journal of Medicinal Chemistry (2022) Vol. 244, pp. 114842-114842
Closed Access | Times Cited: 29
Flavokawain A is a natural inhibitor of PRMT5 in bladder cancer
Shuangjie Liu, Zhuonan Liu, Chiyuan Piao, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 23
Targeting pre-mRNA splicing in cancers: roles, inhibitors, and therapeutic opportunities
Shinsuke Araki, Momoko Ohori, Masato Yugami
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 15
PRT543, a protein arginine methyltransferase 5 inhibitor, in patients with advanced adenoid cystic carcinoma: An open-label, phase I dose-expansion study
Renata Ferrarotto, Paul Swiecicki, Dan P. Zandberg, et al.
Oral Oncology (2023) Vol. 149, pp. 106634-106634
Open Access | Times Cited: 13
Beyond Bruton’s tyrosine kinase inhibitors in mantle cell lymphoma: bispecific antibodies, antibody–drug conjugates, CAR T-cells, and novel agents
Neeraj Jain, Mukesh Mamgain, Sayan Mullick Chowdhury, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 12
Combined inhibition of MTAP and MAT2a mimics synthetic lethality in tumor models via PRMT5 inhibition
Gabriel T. Bedard, Nord Gilaj, Karina Peregrina, et al.
Journal of Biological Chemistry (2023) Vol. 300, Iss. 1, pp. 105492-105492
Open Access | Times Cited: 12
Geopolitical risk and ecological efficiency: A combination approach based on super-efficiency-DEA and extended-STIRPAT models
Qiang Wang, Chen Zhang, Rongrong Li
Journal of Environmental Management (2023) Vol. 351, pp. 119867-119867
Closed Access | Times Cited: 11
Targeting PRMT5 through PROTAC for the treatment of triple-negative breast cancer
Yaxun Guo, Yuzhan Li, Zhongmei Zhou, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 4
PRMT5 inhibition has a potent anti-tumor activity against adenoid cystic carcinoma of salivary glands
Vasudha Mishra, Alka Singh, Michael Korzinkin, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access
PRMT5 Inhibition Enhances Therapeutic Efficacy of Cisplatin via Mediating miR‐29b‐3p‐Mcl‐1 Expression in Lung Adenocarcinoma
Hai-Chao Li, Jiangjiang Fan, Weiwei Shen, et al.
Cell Biology International (2025)
Closed Access
PRMT5 attenuates regorafenib-induced DNA damage in hepatocellular carcinoma cells through symmetric dimethylation of RPL14
Wendi Bi, Xiaojuan Sun, Qiuyun Yi, et al.
Journal of Gastrointestinal Oncology (2025) Vol. 16, Iss. 1, pp. 191-208
Open Access
Best of ESMO: pan-tumor highlights
Thorsten Fuereder
memo - Magazine of European Medical Oncology (2025)
Open Access
NELFCD Promotes Colon Cancer Progression by Regulating the DUSP2–p38 Axis
Weiwei Dai, Min Zhu, Yujing Sun, et al.
Frontiers in Bioscience-Landmark (2025) Vol. 30, Iss. 4
Open Access
Arginine methylation of caspase-8 controls life/death decisions in extrinsic apoptotic networks
Fabian Wohlfromm, Nikita V. Ivanisenko, Sabine Pietkiewicz, et al.
Oncogene (2024) Vol. 43, Iss. 25, pp. 1955-1971
Open Access | Times Cited: 3
The indispensability of methyltransferase-like 3 in the immune system: from maintaining homeostasis to driving function
Mingfu Zhang, Zhixian Gou, Yi Qu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Caffeic acid borate functionalized linear polyglycidol for targeted siRNA delivery in the treatment of primary biliary cholangitis
Ying Liu, Hai-Xia Ma, Qiange Zhang, et al.
International Journal of Biological Macromolecules (2025) Vol. 311, pp. 143673-143673
Closed Access
Mechanistic Insights into CLNS1A-Mediated Chemoresistance and Tumor Progression in Non-small Cell Lung Cancer
Tong‐You Wade Wei, Jiun‐Yi Hsia, Tsung-Ying Yang, et al.
Cancer Letters (2025), pp. 217783-217783
Closed Access
Deciphering the Active Compounds and Mechanisms of HSBDF for Treating ALI via Integrating Chemical Bioinformatics Analysis
Yanru Wang, Xiaojie Jin, Fan Qin, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 15
PRMT5 activates KLF5 by methylation to facilitate lung cancer
Hai Zhou, Jing Chang, Jingjian Zhang, et al.
Journal of Cellular and Molecular Medicine (2023) Vol. 28, Iss. 5
Open Access | Times Cited: 8
The combination of Lonicerae Japonicae Flos and Forsythiae Fructus herb-pair alleviated inflammation in liver fibrosis
Jing-Bei Zhang, Hongliu Jin, Xiao‐Ying Feng, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 13
Novel Chemicals Derived from Tadalafil Exhibit PRMT5 Inhibition and Promising Activities against Breast Cancer
Ziyan Yang, Tian Xiao, Zezhi Li, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4806-4806
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top